Vertex Pharmaceuticals (VRTX) Retained Earnings (2009 - 2026)
Vertex Pharmaceuticals' quarterly Retained Earnings came in at $14.6 billion in Q1 2026, up 21326.43% year-on-year from N/an in Q1 2025, and up 91869.81% quarter-over-quarter from -$15.9 million in Q4 2025.
Vertex Pharmaceuticals has reported Retained Earnings for 18 years, with the latest figure at $14.6 billion in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings rose 21326.43% year-over-year to $14.6 billion; the trailing twelve-month figure through Mar 2026 stood at $14.6 billion (up 21326.43% YoY), and the FY2025 full-year result was -$15.9 million, down 100.17% from the prior year.
- Retained Earnings for Q1 2026 stood at $14.6 billion, up from -$15.9 million in the prior quarter.
- The five-year high for Retained Earnings was $14.6 billion in Q1 2026, with the low at -$101.1 million in Q2 2025.
- Average Retained Earnings over 5 years is $4.7 billion, with a median of $4.0 billion recorded in 2022.
- Year-over-year, Retained Earnings jumped 1267700.0% in 2023 and slumped 101.32% in 2025.
- Tracing VRTX's Retained Earnings over 5 years: stood at $800000.0 in 2022, then jumped by 1267700.0% to $10.1 billion in 2023, then decreased by 5.28% to $9.6 billion in 2024, then tumbled by 100.17% to -$15.9 million in 2025, then surged by 91869.81% to $14.6 billion in 2026.
- The last three Retained Earnings figures came in at $14.6 billion (Q1 2026), -$15.9 million (Q4 2025), and -$64.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -211.85 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -153.89 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -438.66 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -279.00 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 130.89 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 36.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -24.89 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | -622,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.59 Bn |
| Dec 31, 2025 | -15.90 Mn |
| Sep 30, 2025 | -64.50 Mn |
| Jun 30, 2025 | -101.10 Mn |
| Mar 31, 2025 | 68.10 Mn |
| Dec 31, 2024 | 9.61 Bn |
| Sep 30, 2024 | 8.69 Bn |
| Jun 30, 2024 | 7.65 Bn |
| Mar 31, 2024 | 11.24 Bn |
| Dec 31, 2023 | 10.14 Bn |
| Sep 30, 2023 | -3.00 Mn |
| Jun 30, 2023 | 8.14 Bn |
| Mar 31, 2023 | -13.10 Mn |
| Dec 31, 2022 | 800,000.00 |
| Sep 30, 2022 | 5.70 Bn |
| Jun 30, 2022 | 57.50 Mn |
| Mar 31, 2022 | 3.96 Bn |
| Dec 31, 2021 | 3.20 Bn |
| Sep 30, 2021 | 11.54 Mn |
| Jun 30, 2021 | 1.58 Bn |
| Mar 31, 2021 | -33.30 Mn |
| Dec 31, 2020 | -68.50 Mn |
| Sep 30, 2020 | 254.48 Mn |
| Jun 30, 2020 | -14.12 Mn |
| Mar 31, 2020 | -1.25 Bn |
| Dec 31, 2019 | -1.97 Mn |
| Sep 30, 2019 | 18.85 Mn |
| Jun 30, 2019 | -2.49 Bn |
| Mar 31, 2019 | 6.00 Mn |
| Dec 31, 2018 | -2.99 Bn |
| Sep 30, 2018 | 307,000.00 |
| Jun 30, 2018 | -4.67 Bn |
| Mar 31, 2018 | -39.74 Mn |
| Dec 31, 2017 | -5.12 Bn |
| Sep 30, 2017 | -5.22 Bn |
| Jun 30, 2017 | -5.12 Bn |
| Mar 31, 2017 | 16.03 Mn |
| Dec 31, 2016 | -5.37 Bn |
| Sep 30, 2016 | -5.41 Bn |
| Jun 30, 2016 | -5.37 Bn |
| Mar 31, 2016 | -4.90 Mn |
| Dec 31, 2015 | -5.26 Bn |
| Sep 30, 2015 | 1.51 Mn |
| Jun 30, 2015 | -1.71 Mn |
| Mar 31, 2015 | 791,000.00 |
| Dec 31, 2014 | 917,000.00 |
| Sep 30, 2014 | 1.16 Mn |
| Jun 30, 2014 | -23,000.00 |
| Mar 31, 2014 | -297,000.00 |
| Dec 31, 2013 | -306,000.00 |
| Sep 30, 2013 | -550,000.00 |
| Jun 30, 2013 | -1.23 Mn |
| Mar 31, 2013 | -1.15 Mn |
| Dec 31, 2012 | -550,000.00 |
| Sep 30, 2012 | -416,000.00 |
| Jun 30, 2012 | -673,000.00 |
| Mar 31, 2012 | -3.32 Bn |
| Dec 31, 2011 | -1.05 Mn |
| Sep 30, 2011 | -3.57 Bn |
| Mar 31, 2011 | -633,000.00 |
| Dec 31, 2010 | -1.07 Mn |
| Sep 30, 2010 | -677,000.00 |
| Jun 30, 2010 | -558,000.00 |
| Mar 31, 2010 | -1.08 Mn |
| Dec 31, 2009 | -640,000.00 |